Seite - (000199) - in Biomedical Chemistry: Current Trends and Developments

Doyle, K. P., R. P. Simon, et al. (2008). Mechanisms of ischemic brain damage. Neuropharmacology, 55(3), 310-318. Erecinska, M. and F. Dagani (1990). Relationships between the neuronal sodium/potassium pump and energy metabolism. Effects of K+, Na+, and adenosine triphosphate in isolated brain synaptosomes. The Journal of General Physiology, 95(4), 591-616. Evans, J. S. (2008). Dual-processing accounts of reasoning, judgment, and social cognition. Annual Review of Psychology, 59, 255-278. Falkenberg, L. E., R. Westerhausen, et al. (2014). Impact of glutamate levels on neuronal response and cognitive abilities in schizophrenia. NeuroImage. Clinical, 4, 576-584. Fallon, J. H. (1988). Topographic organization of ascending dopaminergic projections. Annuals of the New York Academy of Science, 537, 1-9. Fallon, J. H. and S. E. Loughlin (1985a). Substantia nigra. In G. Paxinos and J. Watson (Eds.), The rat nervous system: A handbook for neuroscientists (pp. 353-374). Sydney: Academic Press. Fallon, J. H. and S. E. Loughlin (1985b). Substantia nigra. The Rat Nervous System. G. Paxinos. New York, Academic Press: 353-374. Fallon, J. H. and S. E. Loughlin (1995). Substantia nigra. In G. Paxinos (Ed.), The Rat Nervous System (pp. 215-237). Sydney: Academic Press. Fallon, J. H. and R. Y. Moore (1978). S Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. Journal of Comparative Neurology, 180(3), 545-580. Farrant, M. and Z. Nusser (2005). Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nature reviews. Neuroscience, 6(3), 215-229. Fatemi, S. H., T. D. Folsom, et al. (2013). mRNA and protein expression for novel GABAA receptors theta and rho2 are altered in schizophrenia and mood disorders; relevance to FMRP-mGluR5 signaling pathway. Translational Psychiatry, 3, e271. Faulkner, P. and J. F. Deakin (2014). The role of serotonin in reward, punishment and behavioural inhibition in humans: Insights from studies with acute tryptophan depletion. Neuroscience and Biobehavior Reviews, 3, 365-78. Filip, M., E. Nowak, et al. (2001). On the role of serotonin 2A/2C receptors in the sensitization to cocaine. The Journal of Physiology & Pharmacology, 52(3), 471-481. Fischer, H., L. Nyberg, et al. (2010). Simulating neurocognitive aging: effects of a dopaminergic antagonist on brain activity during working memory. Biology & Psychiatry 67(6): 575-580. Fonnum, F. (1984). Glutamate: a neurotransmitter in mammalian brain. Journal of Neurochemistry, 42(1), 1-11. Franke, A. G., C. Bonertz, et al. (2011). Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry, 44(2), 60-66. Friedman, L. K. (2006). Calcium: a role for neuroprotection and sustained adaptation. Molecular Intervention, 6(6), 315-329. Gadea, A. and A. M. Lopez-Colome (2001). Glial transporters for glutamate, glycine, and GABA: II. GABA transporters. Journal of Neuroscience Research, 63(6), 461-468. Gamo, N. J., M. Wang, et al. (2010). Methylphenidate and atomoxetine enhance prefrontal function through alpha2-adrenergic and dopamine D1 receptors. Journal of the American